Novo Nordisk
Novo Nordisk’s CagriSema Falls Short of Investor Hopes, Triggers Stock Sell-Off
By john
—
Novo Nordisk (NVO) faced a sharp sell-off on Friday after unveiling weight loss data for its latest GLP-1 product, CagriSema. Despite demonstrating an average ...
